
Liver fibrosis poses a significant risk for liver cancer (HCC, iCCA) development. Research using advanced techniques has identified hepatic stellate cells (HSCs) as sources of collagen-producing cells and cancer-associated fibroblasts (CAFs). Diverse HSC and CAF subpopulations with unique functions influence fibrosis and cancer progression. Transcriptomic and functional parallels between HSCs and CAFs, along with emerging immunological insights, reveal pathways promoting or inhibiting fibrosis and cancer. Ongoing studies offer potential for biomarkers, prognosis, and therapies in HCC and iCCA prevention and treatment. The review underscores the dual roles of HSCs in liver fibrogenesis and cancer promotion.
Like
Save
Share